Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Europe Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)
- Report Code : BMIRE00027448
- Pages : 107
The Europe asparaginase market is expected to grow from US$ 189.17 million in 2022 to US$ 451.68 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2022 to 2028.
Use of Asparaginase in Treatment of Leukemia and Tumors
Asparaginase is an enzyme, derived mostly from bacteria, and has wide applications in the pharmaceutical industry. Asparaginase is widely used to treat various conditions, such as acute myeloid leukemia, acute lymphoblastic leukemia, and non-Hodgkin’s lymphoma. The prevalence of such diseases has increased significantly, creating a demand for effective treatment options. L-asparaginase is an important chemotherapeutic agent that is used in the treatment of lymphoma and leukemia. L-asparaginase breaks down asparagine from blood serum, leading to the death of tumor cells due to the lack of an essential factor for protein synthesis. However, healthy cells are not affected as they can produce asparagine using L-asparagine synthetase, which is available in adequate quantity. Moreover, it is also found to be effective in preventing metastasis from solid tumors.
In addition, various research studies are being conducted on the expansion of the application area of asparaginase in different industries, such as nanomedicine and biomedical engineering, which is contributing to the asparaginase market growth. Furthermore, increasing allergic reactions from E. coli, derived L-asparaginase has increased the use of E. chrysanthemi-derived L-Asparaginase. Many production methods for asparaginase are being developed, which include new bacterial strains, such as Pseudomonas fluorescens, E. coli, Serratia marcescens, Erwinia carotovora, Saccharomyces cerevisiae, and Proteus vulgaris. A few genres of fungi are also used, such as Penicillium, Aspergillus, and Fusarium. Thus, the increasing use o asparaginase in the treatment of diseases is boosting the Europe asparaginase market.
Market Overview
The Europe asparaginase market is segmented into Germany, France, Italy, Spain, the UK, and Rest of Europe. Further, Germany dominated the market in 2022. According to Robert Koch Institute, in 2018, ~12,200 people in Germany were diagnosed with leukemia, and ~4% of them were under 15 years of age. Further, approximately 18,470 people were diagnosed with non-Hodgkin lymphoma in the advanced age. Furthermore, growing pharmaceutical and increasing focus on research and development is expected to boost the market growth. Germany plays an important role in the global healthcare sector and leads in the production and distribution of high-quality pharmaceutical products worldwide. According to the Verband Forschender Arzneimittelhersteller (VFA), the country spends €6.2 billion on R&D, every year. In Germany, approximately half a million people are diagnosed with cancer every year. The German Cancer Research Center (DKFZ) with Helmholtz- ZentrumCentre Dresden-Rossendorf (HZDR) implemented a Cancer Research program that focuses on early diagnostics and treatment of cancer. Medac GMBH received EU-wide marketing authorization for Spectrila (Asparaginase), which is used for the treatment of acute lymphoblastic leukemia in infants, children, and adults. Thus, the growing prevalence of leukemia and increasing R&D activities for the treatment of the disease are expected to boost the market growth during the forecast period.
Europe Asparaginase Market Revenue and Forecast to 2028 (US$ Million)
Europe Asparaginase Market Segmentation
The Europe asparaginase market is segmented based on type, application, end-use industry, and country.Based on type, the Europe asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022.
Based on application, the Europe asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the Europe asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held the larger market share in 2022. Based on country, the Europe asparaginase market has been categorized into the UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany dominated the market in 2022. Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Porton Biopharma; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the Europe asparaginase market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Asparaginase Market – By Type
1.3.2 Europe Asparaginase Market – By Application
1.3.3 Europe Asparaginase Market – By End-Use Industry
1.3.4 Europe Asparaginase Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Asparaginase Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Asparaginase Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Incidences of Leukemia and Increasing Usage Application
5.1.2 Growth of the Pharmaceutical and Food Industry
5.2 Market Restraints
5.2.1 Side Effects Associated With Use of Asparaginase
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.4 Future Trends
5.4.1 Increase in R&D Activities and Investment by Market Players
5.5 Impact Analysis
6. Asparaginase Market– Europe Analysis
6.1 Europe Asparaginase Market Revenue Forecasts and Analysis
7. Europe Asparaginase Market Analysis – By Type
7.1 Overview
7.2 By Type: Europe Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Escherichia Coli
7.2.1.1 Overview
7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Erwinia Chrysanthemi
7.2.2.1 Overview
7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
7.2.3 Pegylated
7.2.3.1 Overview
7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)
7.2.4 Others
7.2.4.1 Overview
7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Asparaginase Market Analysis – By Application
8.1 Overview
8.2 By Application: Europe Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Therapeutic
8.2.1.1 Overview
8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)
8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 Lymphoblastic Lymphoma (LBL)
8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.5 Others
8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Food Processing
8.2.2.1 Overview
8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)
8.2.3 Others
8.2.3.1 Overview
8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Asparaginase Market Analysis – By End-use Industry
9.1 By End-Use: Europe Market Revenue and Forecast Analysis (US$ Million)
9.1.1 Healthcare
9.1.1.1 Overview
9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)
9.1.2 Food Manufacturing
9.1.2.1 Overview
9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Asparaginase Market – Country Analysis
10.1 Overview
10.1.1 Europe: Asparaginase Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 Germany: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3 Germany: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.3.1 Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
10.1.1.2 UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 UK: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3 UK: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.3.1 UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 UK: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
10.1.1.3 France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 France: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3 France: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.3.1 France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 France: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
10.1.1.4 Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.2 Italy: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.3 Italy: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.3.1 Italy: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.4.4 Italy: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
10.1.1.5 Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.2 Spain: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.5.3 Spain: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.3.1 Spain: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.5.4 Spain: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
10.1.1.6 Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.2 Rest of Europe: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Servier Pharmaceuticals LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Biovendor, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Enzymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Taj Pharmaceuticals Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 medac GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Jazz Pharmaceuticals, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Changzhou Qianhong Biopharma Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Porton Biopharma
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 United Biotech (P) Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)
Table 2. Germany Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 10. France Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. France Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
Table 17. Italy Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Europe Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)
Table 26. Recent Inorganic Growth Strategies
Table 27. Recent Organic Growth Strategies
Table 28. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Asparaginase Market Segmentation
Figure 2. Europe Asparaginase Market Segmentation, by Country
Figure 3. Europe Asparaginase Market Overview
Figure 4. Europe Asparaginase Market, By Type
Figure 5. Europe Asparaginase Market, By Country
Figure 7. Europe: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Europe Asparaginase Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Asparaginase Market – Revenue Forecasts and Analysis
Figure 11. By Type: Europe Market Analysis and Forecast 2021 and 2028 (%)
Figure 12. Europe Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Pegylated Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. By Application: Europe Market Analysis and Forecast 2021 and 2028 (%)
Figure 17. Europe Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Food Processing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. By End-Use: Europe Market Analysis and Forecast 2021 and 2028 (%)
Figure 24. Europe Healthcare Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe: Asparaginase Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe asparaginase market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
The List of Companies – Europe Asparaginase Market
● Biovendor, LLC
● Changzhou Qianhong Biopharma Co Ltd
● Creative Enzymes
● Jazz Pharmaceuticals, Inc.
● medac GMBH
● Porton Biopharma
● Servier Pharmaceuticals LLC
● Taj Pharmaceuticals Limited
● United Biotech (P) Limited
At 15.6% CAGR, the Europe Asparaginase Market is speculated to be worth US$ 451.68 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe asparaginase market was valued at US$ 189.17 million in 2022 and is expected to reach US$ 451.68 million by 2028, registering an annual growth rate of 15.6% from 2022 to 2028. Significant growth of pharmaceutical and food industry and rising incidences of leukemia and increasing usage application are the critical factors attributed to the market expansion.
Over the period, the pharmaceutical and food industry has developed at a significant rate and observed various developments to ensure the high quality of food and pharmaceutical products. Moreover, the pharmaceutical industry is developing at a significant rate, supported by the surge in R&D activities, and an increase in investment in the pharmaceutical industry by market players is further driving the market. The food industry is constantly expanding with never-ending increase in the food demand. There is also a continuous rise in novel food products. Nowadays, manufacturers focus on the nutritional quantity of food. The consumption of fried and baked food all around the region has increased substantially and the inclination toward such food items has also surged. Asparaginase is the main amino acid responsible for the reduction of sugar in fried and baked foods, which are condensed with carbonyl sources. Moreover, the increase in population around the region has further contributed to the growth of the pharmaceutical industry and the food industry. The rising population is driving the demand for food products and pharmaceuticals. Thus, an increasing population is contributing to the expansion in the food and pharmaceutical industries, which is driving the asparaginase market.
On the contrary, side effects associated with use of asparaginase hurdles the growth of Europe asparaginase market.
Based on type, the Europe asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held 51.0% market share in 2022, amassing US$ 96.46 million. It is projected to garner US$ 236.12 million by 2028 to expand at 16.1% CAGR during 2022–2028. Based on application, the Europe asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held 60.2% market share in 2022, amassing US$ 113.84 million. It is projected to garner US$ 276.76 million by 2028 to expand at 16.0% CAGR during 2022–2028. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the Europe asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held 60.4% market share in 2022, amassing US$ 114.26 million. It is projected to garner US$ 274.81 million by 2028 to expand at 15.7% CAGR during 2022–2028. Based on country, the Europe asparaginase market has been categorized into the UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 24.8% market share in 2022. It was assessed at US$ 46.83 million in 2022 and is likely to hit US$ 118.19 million by 2028, exhibiting a CAGR of 16.7% during the forecast period. Key players dominating the Europe asparaginase market are Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Porton Biopharma; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited among others.
In May 2021, Jazz Pharmaceuticals acquired GW pharmaceutical company to enhance the R&D capabilities. In Dec 2020, Servier announced the opening of a worldwide Artificial Intelligence (AI) Hub in Montreal in partnership with Centech. This hub will allow different teams in Servier to speed up the discovery, development, and deployment of new therapeutic solutions.
Related Reports
- $3,000.00 – $5,000.00
